Kaletra News
The Competition Bites Trimeris - Motley Fool
Unfortunately for Trimeris, Fuzeon is only approved as a treatment for patients failing other HIV drugs like Abbott Labs' (NYSE: ABT) Kaletra. ...
Key European committee gives the nod to new Kaletra tablet for kids - Aidsmap
Like the adult dose of Kaletra the new paediatric tablet can be taken with or without food and does not require refrigeration. Now that a positive opinion ...
Abbott Gets EMEA Positive Opinion For Lower-Strength Kaletra - CNNMoney.com
Abbott Laboratories (ABT) Monday said its Kaletra tablet, a lower-strength HIV protease inhibitor for pediatric use, was recommended for approval by the ...
Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower ... - CNNMoney.com
all 17 news articles
Abbott shares drop on poor forecast - Ottawa Citizen
US drug sales rose 16.6 per cent and international sales rose 21.3 per cent, driven by successful drugs like Humira and Kaletra and Niaspan in the December ...
Humira fuels Abbott rebound - Chicago Tribune
... the psychiatric drug Depakote, rose 14 percent, to $461 million, while sales of Abbott's anti-AIDS agent Kaletra climbed 25 percent, to $371 million. ...
Thai HIV/AIDS Advocates To Ask Administrative Court For Review Of ... - Medical News Today (press release)
The Thai government in January 2007 issued a compulsory license to produce a lower-cost version of Abbott's antiretroviral Kaletra. ...
Thai HIV/AIDS Advocates To Ask Administrative Court for Review of ... - Kaiser network.org
The Thai government in January 2007 issued a compulsory license to produce a lower-cost version of Abbott's antiretroviral Kaletra. ...
Activists want panel's decision on Aluvia drug reviewed - Bangkok Post
Most of the 12000 HIV-positive people who have developed resistance to first-line anti-retroviral treatment need second-line Aids drugs, namely Kaletra and ...
FDA nod for generic cancer drug - Bangkok Post
The Thai government angered some of the world's biggest pharmaceutical firms by announcing compulsory licensing for the Aids drugs Efavirenz and Kaletra ...
Kaletra RSS Feed